Clarisa Blattner: What Labs Can Learn from Reimbursement Variability Across Health Plans
An argument is made for clinical laboratories to use payer rate transparency as a cornerstone of commercial intelligence
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
An argument is made for clinical laboratories to use payer rate transparency as a cornerstone of commercial intelligence
The three Magellan Diagnostics executives are accused of FDA violations, as well as wire fraud and conspiracy.
On Monday, federal Judge Edward Davila denied the disgraced Theranos CEO’s motion to remain free while she appeals her conviction.
The bipartisan bill was recently reintroduced to amend the FCA in response to a landmark 2016 Supreme Court ruling.
A recent study revealed burnout rates of 49.9 percent among healthcare professionals during the early stages of the COVID-19 pandemic.
Our June virtual event will offer a variety of solutions and strategies for dealing with key issues labs face during times of economic strife.
New legislation would force CMS to change the way it calculates Medicare prices for lab tests.
On Friday, the US federal trade commission ordered Illumina to divest Grail, which it acquired for $8 billion in August 2021.
Last week saw three key settlements, including a lab accused of paying kickbacks for test referrals and billing for unnecessary drug tests.
The U.S. Department of Justice recently announced inflationary increases to civil monetary penalties under the False Claims Act.
Current provider pay rates are “adequate,” says influential committee in its recent report to Congress.